The U.S. Food and Drug Administration (FDA) has announced the approval of Qfitlia (fitusiran), a treatment designed to ...

Additional interests include autoimmune diseases, both autologous and allogeneic bone marrow and peripheral stem cell transplantation, as well as thrombotic and bleeding disorders. SLU’s hemostasis ...

About 30% of people hospitalized due to acquired hemophilia have a bleeding event, while 17% have a blood clot-related ...